Home › Funds › CIBRA Capital Ltd › TERN
CIBRA Capital Ltd position in TERN
TERNS PHARMACEUTICALS INC
CIBRA Capital Ltd reported holding 151,440 shares of TERN (TERNS PHARMACEUTICALS INC) in its Q1 2026 13F filing — a position valued at US$8.0M, representing 3.85% of its reported portfolio and ranking #12 among its reported holdings. CIBRA Capital Ltd first reported this position in Q1 2026.
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
How CIBRA Capital Ltd's TERN position evolved
CIBRA Capital Ltd first disclosed a stake in TERN in Q1 2026 at 151,440 shares (US$8.0M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 151.44K | $7.98M | New |
About TERN and 13F data
TERN (TERNS PHARMACEUTICALS INC) is a company whose sector is not yet classified in our data. 3 other funds we track also report a position in TERN. Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
More on CIBRA Capital Ltd
FAQ
How long has CIBRA Capital Ltd held TERN?
CIBRA Capital Ltd has disclosed TERN holdings in 1 of the last 1 reported quarters, going back to Q1 2026.
What is CIBRA Capital Ltd's current position in TERN?
As of Q1 2026, CIBRA Capital Ltd holds 151.44K shares of TERN (TERNS PHARMACEUTICALS INC), valued at $7.98M, representing 3.85% of its reported portfolio and ranking #12.
Has CIBRA Capital Ltd been buying or selling TERN?
In the latest 13F filing (Q1 2026), CIBRA Capital Ltd newly opened its position in TERN.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.